ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Levels of Physical Activity and Sedentary Lifestyle in Patients With Hematological Cancer Treated With Monoclonal Antibodies as a Monotherapy or Combination Therapy (Immunochemotherapy): A Comparative Study With Healthy Individuals.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Blood cancers account for 7% of all malignant neoplastic diseases worldwide. However, there has been an increase in the survival rate of patients with hematological cancer. These data indicate the need to make patients aware of the importance of physical activity. We aimed to assess the level of physical activity and sedentary lifestyle of patients with hematological cancer treated with monoclonal antibodies as a monotherapy or combination therapy (immunochemotherapy), compared with that of healthy individuals. MATERIAL AND METHODS Patients (n=155) treated for hematological malignancies (study group) and healthy individuals (n=137) were divided using World Health Organization (WHO) recommendations on physical activity into groups of adults aged 18-64 years and 65 years and older. All participants completed the International Physical Activity Questionnaire (IPAQ). RESULTS In the younger adult group, the median IPAQ total score in the study group was 1235.00 compared with 3186.00 in healthy individuals (P<0.0001). Importantly, the study group also differed from healthy individuals in terms of sitting time: 1200.00 vs 360.00 (P<0.0001). In the older adult group, no significant difference was found in the median IPAQ total score: 1188.00 vs 1777.00 (P=0.25); however, significant differences were observed for sitting time: 900.00 vs 300.00 (P<0.0001). CONCLUSIONS Patients with hematological cancer treated with monoclonal antibodies as a monotherapy or combination therapy (immunochemotherapy) show, regardless of age, lower levels of physical activity and longer sitting time than healthy individuals, indicating the need for education and promotion of physical activity in this group of patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.